A New Pandemic? PICKLEBALL INJURIES ON T...

We're back! 

Today's episode is a very complicated topic without clear cut benefits. Expert opinions and modeling data to address a dangerous and serious topic. Let's look at 2 sources: a new study from the Annals of Internal Medicine and an expert opinion from Uptodate. https://www.uptodate. ... Show More

Time restricted eating vs. caloric restriction. Is there a winner in this 1:1:1 12-month trial from Chicago? https://pubmed.ncbi.nlm.nih.gov/37364268/ Time-Restricted Eating Without Calorie Counting for Weight Loss in a Racially Diverse Population : A Randomized Controlled Trial ... Show More

<p>Welcome back to the podcast!</p> <p>This month we start off thinking about sepsis, specifically fluid management and whether a restrictive approach to fluid resuscitation in combination with earlier vasopressors is advantageous over a liberal approach.</p> <p>Next we have a lo ... Show More

  

Benign prostatic hyperplasia (1:30), antidepressants in osteoarthritis (6:10), overdiagnosis of chronic kidney disease (8:00), infertility (10:20), Guardant Health Shield (14:50), and morning vs. bedtime medications for hypertension (17:50). 

Thiazide diuretics (2:20), pancreatic cancer (4:40), DermTech pigmented lesion assay (8:30), chronic low back pain (17:00), hearing aids (23:40), and blood pressure cuff size (27:50). 

Gestational diabetes mellitus (1:40), steroid injections and blood glucose (5:40), heart failure management (8:10), BD Max vaginal panel (13:20), benzodiazepine use disorder (15:20), chlorthalidone vs. hydrochlorothiazide (19:10). 

Corticosteroids for low back pain (1:40), glaucoma (4:20), screening for obstructive sleep apnea (10:10), polycystic ovary syndrome (13:20), diabetic peripheral neuropathy (17:50), and antiplatelet agents for deep venous thrombosis (20:10). 

Join Dr Peters for an update in approaches to managing microvascular complications. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/933885?src=mkm_podcast_addon_933885 

<p>We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ... Show More

Systemic lupus erythematosus (1:40), Bell palsy (6:30), outpatient management of COVID-19 (10:20), metformin or lifestyle changes to prevent diabetes (13:50), acetazolamide for acute heart failure (18:00), low back pain (20:20), and a brand new game (22:20).